3 completed, 2 terminated. 5 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 5 | Completed 3, Terminated 2 |
Follow Sleep Disorders: new trials by email Literature Review of Sleep Disorders trials Research Report on Sleep Disorders
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Clinical Trial of the Safety and Tolerability of the Drug MMH-450 in Healthy Volunteers MMH-450 - Sleep Disorders | Phase 1 | Completed | Materia Medica Holding | 18 | 2025-08-15 | 2026-08-04 |
| Providing "Good Sleep" for ICU Sedation Normal saline infusion, Dexmedetomidine, Propofol - Sleep Disorders | Phase 1 | Terminated | University of California, San Francisco | 3 | 2012-05-01 | 2026-06-05 |
| Methadone Hydrochloride as First-Line Therapy in Treating Patients With Chronic Neuropathic Cancer Pain methadone hydrochloride, questionnaire administration, management of therapy complications - Nausea and Vomiting, Pain | Phase 1 | Terminated | NCIC Clinical Trials Group | 8 | 2010-06-17 | 2024-02-12 |
| A Single-centre Open Label Study to Investigate the Effect of Repeat Doses of SB-649868 on the Pharmacokinetics of Simvastatin and Atorvastatin in Healthy Male Volunteers. Atorvastatin, Simvastatin, SB649868 - Sleep Disorders | Phase 1 | Completed | GlaxoSmithKline | 30 | 2010-01-18 | 2017-07-21 |
| Study to Investigate Safety, Tolerability, Pharmacokinetics and Cardiac Function After Repeat Doses of SB-649868 in Healthy-volunteers SB-649868 - Sleep Disorders | Phase 1 | Completed | GlaxoSmithKline | 72 | 2009-08-27 | 2017-06-20 |
Sleep Wake Disorders (5) · Multiple Endocrine Neoplasia Type 1 (1) · Nausea (1) · Pain (1) · Sleep Hygiene (1) · Vomiting (1)
Mental Disorders (5) · Nervous System Diseases (5) · Neurologic Manifestations (5) · Pathological Conditions, Signs and Symptoms (5) · Signs and Symptoms (5) · Behavior (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Endocrine Gland Neoplasms (1) · Endocrine System Diseases (1) · Genetic Diseases, Inborn (1) · Health Behavior (1) · Multiple Endocrine Neoplasia (1) · Neoplasms (1) · Neoplasms by Site (1) · Neoplasms, Multiple Primary (1)
N-((1-((5-(4-fluorophenyl)-2-methyl-4-thiazolyl)carbonyl)-2-piperidinyl)methyl)-4-benzofurancarboxamide (2) · Atorvastatin (1) · Dexmedetomidine (1) · Methadone (1) · Propofol (1) · Simvastatin (1)
GlaxoSmithKline (2) · Materia Medica Holding (1) · NCIC Clinical Trials Group (1) · University of California, San Francisco (1)
Germany (2) · Canada (1) · Russia (1) · United States (1)
Bruno Gagnon, MD, MSC (1) · Mervyn Maze, MB, ChB (1) · Ray Viola (1)